Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
28022
Beskrivning
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Nyckelord
Versioner (2)
- 2017-12-10 2017-12-10 -
- 2018-01-02 2018-01-02 -
Rättsinnehavare
Prof. Dr. med. Georg Heß
Uppladdad den
10 december 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
End of study GOAL Trial B-cell Lymphoma NCT02499003
End of study GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
End of study GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Date of study end
Item
Date of study end
date
follow-up completion
Item
Did the subject complete the follow-up?
boolean
Item
If 'no', please specify reason(s) for early follow-up termination:
text
Code List
If 'no', please specify reason(s) for early follow-up termination:
CL Item
Withdrawal of consent (Withdrawal of consent)
CL Item
Death (Death)
CL Item
Lost to Follow-Up (Lost to Follow-Up)
CL Item
Other (Other)
Date of death
Item
If 'death': Date
date
CL Item
Progression of underlying disease (Progression of underlying disease)
CL Item
Unknown (Unknown)
CL Item
Other (Other)
other reason for early follow-up termination
Item
If 'other' reason for early follow-up termination, please specify:
text